series-c-plus
Stage
About
Ambio Holdings, Inc is a contract development and manufacturing organization (CDMO) that develops and manufactures peptide active pharmaceutical ingredients (APIs) and peptide-based therapeutics, and provides formulation and cGMP manufacturing services with operations in the United States and China.
Explore Ambio Holdings, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.